Evidence map

ReviewDiabetes, obesity & metabolism2020

Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual framework.

Milton PackerPubMed ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2020
2021
2022
2023
2024
2025
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31916329